LakeShore Biopharma Co. L...

NASDAQ: LSB · Real-Time Price · USD
0.79
0.00 (0.00%)
At close: Aug 15, 2025, 3:59 PM
0.79
0.00%
After-hours: Aug 15, 2025, 04:00 PM EDT

LakeShore Biopharma Ltd Cash Flow Statement

Financials in CNY. Fiscal year is April - March.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Net Income
-433.46M -145.48M -545.73K -191.83M
Depreciation & Amortization
42.19M 36.69M 31.15M 27.91M
Stock-Based Compensation
9.79M 3.5M 7.76M 76.76M
Other Working Capital
39.23M -6.45M -64.05K -44.29K
Other Non-Cash Items
153.78M 4.42M -3.45K 2.23M
Deferred Income Tax
-21.73M 1.13M 4.94M 17.45M
Change in Working Capital
-45.79M -92.75M -64.05K -186.68M
Operating Cash Flow
-295.23M -182.47M -613.23K -246.61M
Capital Expenditures
-44.25M -57.05M -298.93M -104.88M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a -200M n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-44.25M -56.98M -200M -104.24M
Debt Repayment
-78.93M 100.88M 364.56M 8.26M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
284.2M 216.57M -163.06M n/a
Financial Cash Flow
205.26M 317.45M 201.5M 739.26M
Net Cash Flow
-123.82M 99.3M -389.57M 388.41M
Free Cash Flow
-339.48M -239.52M -299.55M -351.49M